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Background: Persistent left superior caval vein (PLSCV) is a rare, anatomically 
diverse developmental anomaly of systemic veins. Clinically asymptomatic PLSCVs 
are detected incidentally during medical procedures that utilise systemic veins, such 
as cardiac implantable electronic device (CIED) placement, and whose successful 
completion depends on favourable morphometric parameters of these vessels. 
The aim of this paper was to present topography and morphometry of PLSCV 
variations encountered during CIED implantation procedures.
Materials and methods: We analysed a group of 5,010 patients for detection 
of PLSCV during de-novo CIED implantation procedures with transvenous lead 
placement in the years 2003–2015. PLSCVs were detected intraprocedurally based 
on venographic images illustrating the venous anomaly and its morphometric 
parameters, and were subsequently confirmed via postoperative diagnostics.
Results: PLSCVs were detected in 10 patients (mean age 66.0 ± 14.0 years; 
5 females and 5 males), who constituted 0.2% of the analysed group. There were 
6 cases of double superior vena cava (DSVC), 3 of which had a brachiocephalic 
vein (BCV) connection and did not have BCV bridging. Four patients with a PLSCV 
had right superior vena cava agenesis; this very rare variation is known as ‘single 
PLSCV’. All of the detected PLSCV variations drained into the right atrium via the 
coronary sinus.
Conclusions: Our data from a period of 13 years illustrate how rare the PLSCV-type 
venous anomaly is. The three distinct anatomical PLSCV types showed inter-
-individual morphometric variations. Due to asymptomatic nature of this anomaly, 
all cases were detected incidentally, during CIED implantation procedures. (Folia 
Morphol 2017; 76, 1: 58–65)
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IntroductIon
Anatomical variations of the venous system may 
affect the course of medical procedures involving car-
diac implantable electronic device (CIED) placement. 
These procedures are conducted with an expectation 
of a certain, typical spatial arrangement of vessels, 
including systemic veins [8, 27]. However, certain ve-
nous structural anomalies that are not accompanied 
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by symptomatic congenital heart defects may remain 
long undetected and be discovered incidentally only 
during cardiological, anaesthetic, or diagnostic pro-
cedures [3, 12, 13, 18, 22, 23]. One of such venous 
variations is the presence of persistent left superior 
caval vein (PLSCV) (Fig. 1).
The most common approach in CIED, pacemaker 
(PM), and implantable cardioverter-defibrillator (ICD) 
implantation procedures is the use of venous vessels 
for cardiac lead insertion. Successful transvenous 
lead advancement is determined by favourable ana-
tomical arrangement of venous structures along 
the course from the site of lead insertion to its final 
placement [5, 7].
In this study, the developmental venous anomaly 
(i.e. PLSCV) was detected as a result of visualising 
the contrast-enhanced venous lumen during CIED 
implantation. The fact that these anomalies were 
undetected prior to the procedure due to their asymp-
tomatic nature resulted in venography being the only 
diagnostic assessment available intraprocedurally. The 
selection of the optimal approach and the route of 
cardiac lead insertion were made possible by visualis-
ing anatomical and morphometric parameters of the 
altered venous system [4].
The aim of this paper was to illustrate PLSCV vari-
ations encountered during CIED implantation pro-
cedures.
MAtErIALS And MEtHodS
We analysed 5,010 CIED implantation procedures 
with transvenous lead insertion performed at our 
centre in the years 2003–2015, including de-novo PM 
and ICD implantations. During the analysed period, 
10 cases of PLSCV-type systemic vein anomalies were 
detected (Table 1).
The CIEDs were implanted in the left infraclavicu-
lar region and the cardiac leads were inserted using 
cephalic vein (CV) cut-down and/or axillary vein (AV) 
or subclavian vein (SV) puncture.
In order to visualise the cause of problems emerging 
during cardiac lead advancement and/or in situations 
where the vessel had an atypical course, a contrast 
agent was administered into the ipsilateral CV or AV/SV. 
Contrast flow in the veins was recorded in an anterior-
posterior view via C-arm angiocardiography. Films were 
taken at 8 Fr/s with individual frame documentation 
(some images were used as figures presented in this 
article). Contrast flow in the evaluated vessels was visu-
alised following administration of 15–30 mL (mean 20 
mL) of a contrast agent, depending on interindividual 
variations in venous bed volume in the evaluated area.
After the procedure, in order to more spe-
cifically determine the intraprocedurally detected 
anomaly, a computed tomography (CT) scan and/or 
a 2-dimensional/3-dimensional (2D/3D) ultrasound 
examination was performed in some cases, depend-
ing on indications.
Our statistical analysis used numerical variables 
in the form of mean values.
rESuLtS
A total of 5,010 de-novo CIED implantation proce-
dures with transvenous cardiac lead placement were 
performed in the analysed period of time. The study 
group comprised 52% of females and 48% of males. 
Venous access via the left infraclavicular region was 
used in 97% of patients.
Figure 1. Morphoanatomical variations of the developmental systemic vein anomaly known as persistent left superior caval vein (PLSCV) 
presented in this paper; A. Double superior vena cava (DSVC) with a left brachiocephalic vein (BCV) bridge; B. DSVC without brachiocephalic 
vein bridging; C. Single PLSCV; SVC — superior vena cava.
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Persistent left superior caval vein were detected 
in 10 patients (mean age 66 ± 14 years), including 
9 cases during PM implantation and 1 case during 
ICD implantation. This venous anomaly was detected 
in 5 females (mean age 73 ± 15 years) and 5 males 
(mean age 60 ± 10 years), who constituted 0.2% of 
the analysed population. Three morphoanatomical 
variations of this venous anomaly were detected and 
the recorded visual evidence of the most representa-
tive cases was presented in this article.
In all 10 cases, the PLSCVs drained into the right 
atrium (RA) via the coronary sinus (CS).
Three patients (mean age 65 ± 25 years) were 
shown to have double superior vena cava (DSVC) with 
a brachiocephalic vein (BCV) bridge. This anatomical 
variation was illustrated with the venography im-
age obtained during a CIED implantation procedure 
(Fig. 2).
The venous anomaly cases were characterised by 
a relatively low left BCV diameter, which is likely due to 
the coexistence of two venous drainage routes via the 
right superior vena cava (RSVC) and left superior vena 
cava (LSVC), sharing between them venous drainage 
of the thorax.
Table 1. Venous anomaly types, patients’ sex, patients’ age at the time of first cardiac implantable electronic device (CIED)  
implantation, procedure date, electrocardiographic indications for CIED implantation, CIED type
PLSVC Sex Age Electrocardiogram Procedure date CIED type
DSVC + BCV Male 41 SSS 2003 AAI
Female 90 AF + CHB 2004 VVI
Male 63 SR + CHB 2015 DDD
DSVC – BCV Female 77 TBS 2006 DDD
Female 80 SR + CHB 2006 VVI
Male 61 TBS 2007 DDD
SSVC Female 52 SR + CHB 2009 DDD
Male 67 SR + CHB 2013 VVI
Female 66 VT 2014 ICD-VR
Male 63 AF + CHB 2015 VVI
AAI — single-chamber atrial pacemaker; AF — atrial fibrillation; BCV — brachiocephalic vein; CHB — complete heart block; DDD — dual-chamber (atrioventricular) pacemaker; DSVC — 
double superior vena cava; ICD-VR — single-chamber implantable cardioverter-defibrillator; PLSVC — persistent left superior caval vein; SR — sinus rhythm; SSS — sick sinus syndrome; 
SSVC — single superior vena cava; TBS — tachycardia-bradycardia syndrome; VT — ventricular tachycardia; VVI — single-chamber ventricular pacemaker
Figure 2. Double superior vena cava (DSVC) + brachiocephalic vein (BCV) (male, 63 years old); A. Contrast flow through right superior vena 
cava (RSVC; arrow) into the right atrium; B. Contrast-enhanced course and shape of persistent left superior vena cava (PLSVC) and  its drain-
age into the coronary sinus; C. A contrast-filled narrow BCV (arrows). D. A fluoroscopically visualised wide cephalic vein, with its borders 
marked by cardiac leads (double-headed arrow).
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Three patients (mean age 73 ± 10 years) had DSVC 
without BCV bridging. This venous variation was illus-
trated via intraprocedural bilateral venography (Fig. 3).
Four patients (mean age 62 ± 9 years) developed 
a form of a single PLSVC with concomitant RSVC agenesis. 
An intraprocedural contrast venography of the right 
forearm showed smooth contrast flow through the 
BCV into the LSVC and, subsequently, through the CS 
into the RA (Fig. 4).
Transthoracic echocardiography (TTE) conducted 
after the procedure showed no evidence of a coex-
isting congenital heart defect in any of the patients. 
3D TTE showed the special position of cardiac leads 
and heart chambers (assessment conducted after the 
procedure) (Fig. 5).
Computed tomography scans showed the PLSCVs 
presented in this article to have similar topography, 
which was illustrated in Figure 6. The LSVC courses 
vertically from the point of confluence of the left jugular 
vein and left SV, located posterior to the articulation 
of the first rib and the sternum (Th2/Th3 level). In its 
initial segment the PLSVC lies anterior and lateral to 
the aortic arch, at the level of Th6 the vessel is adjacent 
anteriorly to the left pulmonary vein, and below — to 
Figure 3. Double superior vena cava with brachiocephalic vein (BCV) agenesis (male, 61 years old); A. Fluorography visualised a normally 
formed right BCV (white arrows); B. Contrast flow via the persistent left superior caval vein (white arrows) shows the lumen of the vessel and 
a lack of BCV. C. An intraprocedural fluoroscopy image showing the position of both leads in the coronary sinus (white double-headed arrow) 
illustrates the approximate diameter of its lumen. The diameter of the left superior vena cava lumen diameter appears to be markedly  
narrower than that in the corresponding segment of the right superior vena cava (A, B).
Figure 4. Single persistent left superior vena cava (SPLSVC); female, 66 years old; A. Contrast agent administered into the veins of the right 
forearm showed the absence of right superior vena cava and the presence of a brachiocephalic vein (BCV) bridge draining into the left supe-
rior vena cava (LSVC); B. Another venography from the left side confirmed the presence and course of LSVC; C. Contrast flow visualised the 
drainage of the LSVC into the right atrium via a wide coronary sinus (CS).
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the left main bronchus, finally draining into the CS at 
the level of Th8/Th9 (Figs. 7, 8). The diameter of these 
vessels in the evaluated cases ranged from 2 × 25 mm 
to 18 mm and depended on the level at which the ves-
sel was measured.
Known dimensions of cardiac lead components 
(e.g. Medtronic screw-in leads with a deployed lead tip 
measuring 18 mm, Fig. 3C), helped indirectly estimate 
the vascular diameter already during the procedure.
dIScuSSIon
The lack of symptoms in the case of vascular 
anomalies is the reason why they can be detected 
only in favourable circumstances, an example of 
which is PLSCV [7, 11, 19, 23]. The PLSCV, found in 
approximately 0.3–0.5% of the population, is usu-
ally detected on echocardiography, CT, postmortem, 
or invasive cardiac procedures, such as transvenous 
CIED implantation [12, 13, 15, 22]. The population 
analysed in our centre exhibited a 0.2% prevalence 
of this venous anomaly.
During normal embryonic development, the ini-
tially symmetrical venous system is composed of two 
pairs of cardinal veins (anterior and posterior), col-
lecting blood from the cephalic and caudal regions 
of the embryo, respectively. These pairs of veins anas-
Figure 5. Male, 61 years old; cardiac implantable electronic device with cardiac leads introduced through the persistent left superior caval 
vein into the right atrium (RA) via the coronary sinus (CS); A. Two-dimensional transthoracic echocardiography: a visible cardiac lead (arrow) 
within the CS and RA (postprocedural image); B. Three-dimensional transthoracic echocardiography: cardiac lead position (arrow) in the CS 
(double-headed arrow) measuring 18 mm in diameter; C. The course of cardiac leads illustrated via intraprocedural anteroposterior fluoros-
copy shows the morphometric parameters of the CS (double-headed arrow); RV — right ventricle.
Figure 6. Male, 63 years old; a computed tomography scan showing the layout of single persistent left superior vena cava (LSVC) with 
respect to other thoracic structures and organs; A. A frontal cross section showing a lack of right superior vena cava in its typical location 
(oval); B. A reconstruction adjusted to visualise LSVC drainage into the right atrium via the coronary sinus (CS).
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tomose to form the right and left common cardinal 
veins (ducts of Cuvier). The left common cardinal vein 
forms the CS and oblique veins of the left atrium 
(LA). In gestational week 8, the BCV forms as a re-
sult of anastomosis of both, right and left, superior 
cardinal veins. In its mature form, the final segment 
of the right anterior cardinal vein forms the RSVC. By 
gestational week 20, in normally developing embryo 
the left tube atrophies and blood flow is redistributed 
to the right side. The anatomical remnants are Mar-
shall’s ligament and vein coursing over the LA and 
marking the anatomical beginning of the CS, which 
ends in the RA [1, 2, 21]. The presence of PLSCV is 
a consequence of a lack of normal atrophy of the left 
anterior cardinal vein in the embryonic life. An effect 
of a patent PLSCV in adult life is drainage of venous 
blood into the CS or directly into the RA, rarely into 
the LA (90% and 10% of cases, respectively) [3]. In 
the absence of coexisting congenital defects, the 
presence of PLSCV draining into the RA is typically 
asymptomatic.
A PLSCV draining into the LA with a left-to-right 
shunt is observed sporadically. Such a configuration 
is usually associated with symptomatic cardiovascular 
pathologies (unroofed coronary sinus defect type I) 
[7, 9, 24, 27, 28].
The PLSCV more commonly coexists with congeni-
tal heart defects (3–10%), with the literature report-
ing various rates of PLSCV prevalence in children and 
adults, as well as for different diagnostic techniques 
[6, 13, 18, 20].
The PLSCVs detected in our patient group over the 
analysed period of time can be classified into three 
distinct variations: two variations of DSVC (one with 
Figure 7. Double superior vena cava; female, 80 years old; a computed tomography (CT) scan showing the location of the vessel with respect 
to surrounding thoracic organs; A. A frontal cross-sectional CT view of the right superior vena cava (RSVC) and its drainage into the right 
atrium; B. A CT scan showing the presence of the left superior vena cava (LSVC) and an absence of the brachiocephalic vein.
Figure 8. A, B. Differentiation of the detected left superior vena cava (LSVC) variations and their locations with respect to neighbouring anatomical 
structures based on axial computed tomography cross sections; A. Single persistent LSVC; male, 63 years old: a cross section at the level of Th7, 
(the vessel’s lumen measures 18 mm at the level of Th6); B. Double superior vena cava; female, 80 years old: an axial cross section of both vessels; 
at the level of Th6 the LSVC lumen measures 15 mm, right superior vena cava (RSVC); 17 mm (the hyperdense structure within the LSVC lumen is  
a cardiac lead); C. Brachiocephalic vein (BCV): a “transverse” cross section at the level of Th3/Th4; the vessel’s lumen measures 11 mm.
64
Folia Morphol., 2017, Vol. 76, No. 1
and the other without BCV bridging) and a single 
PLSVC with RSVC agenesis [3, 10, 25, 26]. In 6 out 
of 10 (60%) cases of PLSCVs the vessel was found to 
coexist with the RSVC.
Failure of a bridge to form between both ante-
rior cardinal veins leads to a lack of BCV connecting 
the DSVC. This vascular configuration was found 
in 3 out of 6 (50%) of the analysed patients [18, 
22]. A DSVC with a BCV bridge was also found in 
3 cases; however, this vascular configuration may 
be somewhat more common, due to the fact that 
cases where the angle formed by the BCV bridge 
facilitates direct lead advancement to the RSVC may 
remain undetected.
Developmental malformations of the right car-
dinal vein leading to RSVC agenesis were observed 
in 4 in 10 (40%) evaluated patients. This variation is 
noteworthy because venous drainage from the up-
per part of the body into the RA takes place solely 
via the PLSCV, posing a haemodynamic burden on 
the CS [18, 22, 23].
Transthoracic echocardiography assessments per-
formed in the evaluated patients revealed no congeni-
tal heart defects. Despite technical advancement of 
the imaging equipment and quality, the use of this 
method in our study was limited to obtaining data 
on CS size (potential effects of increased venous flow) 
and locating lead position. CT scans confirming the 
initial venography-based diagnosis were the only 
method of obtaining more precise data on PLSCV 
location in relation to thoracic structures and organs 
[14, 17].
Literature reports typically present isolated cases 
of a specific PLSCV variation [4, 11, 16, 19, 25]. This 
article presents PLSCV topography and morphometry 
in 10 cases of this venous malformation diagnosed 
during CIED implantation procedures, based on vari-
ous techniques used to visualize each of the three 
representative variations.
Limitations of the study
All CIED implantation procedures at our centre 
are conducted on the left side of the body, which 
could affect the estimated prevalence of this venous 
anomaly in the analysed population with respect to 
its actual prevalence in the general population.
The clinical as well as outpatient follow-up aspects 
of our study were limited in favour of presenting 
various imaging methods used to visualise PLSCV 
morphometry and topography.
concLuSIonS
The PLSCV-type venous anomaly was detected in 
0.2% of the analysed patients undergoing de-novo 
CIED implantation procedures.
The three distinct anatomic PLSCV variations 
showed interindividual morphometric differences.
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